Logo image of BHSE

BULL HORN HOLDINGS CORP (BHSE) Stock Fundamental Analysis

NASDAQ:BHSE - Nasdaq - VGG1686P1062 - Common Stock - Currency: USD

11.95  +3.65 (+43.98%)

After market: 10.82 -1.13 (-9.46%)

Fundamental Rating

2

Overall BHSE gets a fundamental rating of 2 out of 10. We evaluated BHSE against 0 industry peers in the Unkown industry. While BHSE seems to be doing ok healthwise, there are quite some concerns on its profitability. BHSE has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year BHSE was profitable.
In the past year BHSE has reported a negative cash flow from operations.
BHSE Yearly Net Income VS EBIT VS OCF VS FCFBHSE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 0 5M 10M 15M

1.2 Ratios

Industry RankSector Rank
ROA 17.94%
ROE 20.48%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BHSE Yearly ROA, ROE, ROICBHSE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 0 20 -20 -40

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for BHSE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BHSE Yearly Profit, Operating, Gross MarginsBHSE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021

More info and screens

5

2. Health

2.1 Basic Checks

Compared to 1 year ago, BHSE has about the same amount of shares outstanding.
BHSE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BHSE Yearly Shares OutstandingBHSE Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2M 4M 6M 8M
BHSE Yearly Total Debt VS Total AssetsBHSE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 20M 40M 60M

2.2 Solvency

An Altman-Z score of 16.02 indicates that BHSE is not in any danger for bankruptcy at the moment.
There is no outstanding debt for BHSE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 16.02
ROIC/WACCN/A
WACCN/A
BHSE Yearly LT Debt VS Equity VS FCFBHSE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 0 20M 40M 60M

2.3 Liquidity

BHSE has a Current Ratio of 0.13. This is a bad value and indicates that BHSE is not financially healthy enough and could expect problems in meeting its short term obligations.
BHSE has a Quick Ratio of 0.13. This is a bad value and indicates that BHSE is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.13
Quick Ratio 0.13
BHSE Yearly Current Assets VS Current LiabilitesBHSE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 200K 400K 600K 800K

More info and screens

0

3. Growth

3.1 Past

The earnings per share for BHSE have decreased strongly by -52.13% in the last year.
EPS 1Y (TTM)-52.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%83.11%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BHSE Yearly Revenue VS EstimatesBHSE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021
BHSE Yearly EPS VS EstimatesBHSE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 19.27, BHSE is valued on the expensive side.
BHSE is valuated rather cheaply when we compare the Price/Earnings ratio to 29.62, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 19.27
Fwd PE N/A
BHSE Price Earnings VS Forward Price EarningsBHSE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BHSE Per share dataBHSE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BHSE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BULL HORN HOLDINGS CORP

NASDAQ:BHSE (10/28/2022, 8:18:14 PM)

After market: 10.82 -1.13 (-9.46%)

11.95

+3.65 (+43.98%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners2.16%
Inst Owner Change-51.08%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap112.03M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 19.27
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 3.86
P/tB 3.86
EV/EBITDA N/A
EPS(TTM)0.62
EY5.19%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.08
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS0
BVpS3.09
TBVpS3.09
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 17.94%
ROE 20.48%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.13
Quick Ratio 0.13
Altman-Z 16.02
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-52.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%83.11%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-319.03%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-319.03%
OCF growth 3YN/A
OCF growth 5YN/A